Cargando…
IN VITRO TO IN VIVO: COMBATING MULTIDRUG-RESISTANT ENTEROBACTERIACAE IN THE AGE OF COVID-19
Autores principales: | WALKER, CHRISTOPHER B, DAOUD, WISAM, M. WESTBROOK, AMANDA, M ZETOLA, NICOLA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548721/ http://dx.doi.org/10.1016/j.chest.2022.08.442 |
Ejemplares similares
-
SECONDARY BACTERIAL INFECTION WITH MULTIDRUG-RESISTANT PATHOGENS WAS COMMON IN INTUBATED CRITICALLY ILL PATIENTS WITH COVID-19: WHAT ARE PREDICTORS FOR POOR OUTCOMES?
por: SADIGOV, ALIZAMAN, et al.
Publicado: (2021) -
VACCINATED WITH A TWIST: BREAKTHROUGH COVID-19 IN AN IMMUNOCOMPROMISED PATIENT
por: DAOUD, DANA, et al.
Publicado: (2021) -
ARDS IN CYSTIC FIBROSIS PATIENT WITH DOUBLE LUNG TRANSPLANT SURVIVES SARS-COV-2
por: Modugula, Sujith, et al.
Publicado: (2020) -
BASELINE CHARACTERISTICS AND PREDICTORS FOR ALL-CAUSE MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
por: CHAROENPONG, PRANGTHIP, et al.
Publicado: (2021) -
OUTCOMES OF PATIENTS WITH COVID-19 ON ANTIHYPERTENSIVE MEDICATIONS IN SOUTHERN PENNSYLVANIA
por: CHAN, VERNON, et al.
Publicado: (2021)